| Melanoma classification and management in the era of molecular medicine S Rashid, M Shaughnessy, H Tsao Dermatologic clinics 41 (1), 49-63, 2023 | 28 | 2023 |
| Effect of the COVID-19 pandemic on delayed skin cancer services S Rashid, H Tsao Dermatologic Clinics 39 (4), 627-637, 2021 | 27 | 2021 |
| The molecular context of vulnerability for CDK9 suppression in triple wild-type melanoma SM Guhan, M Shaughnessy, A Rajadurai, M Taylor, R Kumar, Z Ji, ... Journal of Investigative Dermatology 141 (8), 2018-2027. e4, 2021 | 8 | 2021 |
| Recognition, staging, and management of melanoma S Rashid, H Tsao Medical Clinics 105 (4), 643-661, 2021 | 6 | 2021 |
| Predicting resource-dependent maternal health outcomes at a referral hospital in Zanzibar using patient trajectories and mathematical modeling D Nadkarni, A Minocha, H Harpaldas, G Kim, A Gopaluni, S Gravelyn, ... Plos one 14 (3), e0212753, 2019 | 6 | 2019 |
| Modeling patient access to therapeutic oxytocin in Zanzibar, Tanzania D Nadkarni, S Gravelyn, M Brova, S Rashid, R Yee, D Guttieres, K Clifford, ... BMC Health Services Research 18, 1-10, 2018 | 4 | 2018 |
| New insights into melanoma tumor syndromes S Rashid, S Gupta, SR McCormick, H Tsao JID Innovations 2 (6), 100152, 2022 | 2 | 2022 |
| Unsupervised Phenotype-based Clustering of Clinicopathological Features in Cutaneous Melanoma S Rashid, N Klebanov, WM Lin, H Tsao JID Innovations, 100047, 2021 | 2 | 2021 |
| Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and Vitiligo S Rashid, I Molotkov, N Klebanov, M Shaughnessy, MJ Daly, M Artomov, ... JID Innovations 3 (6), 100217, 2023 | | 2023 |
| 638 Inverse genetic risk between cutaneous melanoma, basal cell carcinoma, squamous cell carcinoma and vitiligo S Rashid, N Klebanov, M Shaughnessy, M Daly, M Artomov, H Tsao Journal of Investigative Dermatology 142 (8), S110, 2022 | | 2022 |
